Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$17.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Apr 1 | SGMO | Sangamo Therapeutics, INC | AGRANT◆ | 225,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | SGMO | Sangamo Therapeutics, INC | FTAX | 5,119 | $0.47 | $2.4K | -2.7% | Open the original filing on SEC.gov |
| Feb 24 | SGMO | Sangamo Therapeutics, INC | FTAX | 832 | $0.4725 | $393 | -0.4% | Open the original filing on SEC.gov |
| Jan 22 | SGMO | Sangamo Therapeutics, INC | FTAX | 7,721 | $0.3985 | $3.1K | -3.9% | Open the original filing on SEC.gov |
| Nov 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 723 | $0.4166 | $301 | -0.4% | Open the original filing on SEC.gov |
| Oct 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 6,708 | $0.66 | $4.4K | -3.3% | Open the original filing on SEC.gov |
| Aug 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 723 | $0.5863 | $424 | -0.4% | Open the original filing on SEC.gov |
| Jul 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 6,708 | $0.4798 | $3.2K | -3.2% | Open the original filing on SEC.gov |
| May 24, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 723 | $0.4733 | $342 | -0.4% | Open the original filing on SEC.gov |
| Apr 22, 2025 | SGMO | Sangamo Therapeutics, INC | FTAX | 6,708 | $0.7763 | $5.2K | -3.1% | Open the original filing on SEC.gov |